IP Library Granted Patent US 9,615,915
Granted Patent B2
US 9,615,915 · App. 14/808,852 · Granted Apr 11, 2017

Implantable devices and techniques for oncoplastic surgery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,615,915
App. No.
14/808,852
Granted
Apr 11, 2017
Kind
B2
Abstract

Described herein are devices for placement in surgically created soft tissue spaces, potential spaces, or cavities. The implantable devices generally include a bioabsorbable body having an open framework that facilitates attachment of tissue thereto in a manner that helps avoid post-surgical deformities. Methods for using the implantable devices in oncoplastic surgery are further described.

Claims (26)

1. A method of reconstituting the contour of a breast after surgical removal of tissue comprising:

placing an oncoplastic device within a cavity or space, the cavity or space formed by the surgical removal of tissue, wherein the oncoplastic device comprises a body having a non-contiguous external perimeter surface, and further comprises a semi-rigid open framework to provide structural support to the cavity or space and allow body fluids and tissue to pass through the non-contiguous external perimeter surface and into the body of the device

to reconstitute the contour of the breast.

2. The method of claim 1 , further comprising manipulating the tissue surrounding the oncoplastic device.

3. The method of claim 2 , wherein manipulating the tissue surrounding the oncoplastic device comprises attaching the surrounding tissue to the oncoplastic device.

4. The method of claim 2 , wherein manipulating the tissue surrounding the oncoplastic device comprises wrapping the surrounding tissue around the non-contiguous external perimeter surface of the oncoplastic device.

5. The method of claim 4 , wherein the wrapped tissue is sutured to secure it around the non-contiguous external perimeter of the oncoplastic device.

6. The method of claim 3 , wherein attaching the surrounding tissue comprises suturing the tissue to the open framework.

7. The method of claim 1 , wherein the cavity or space is formed by the surgical removal of tumor tissue.

8. The method of claim 1 , wherein the open framework comprises a bioabsorbable material.

9. The method of claim 8 , wherein the bioabsorbable material is mammographically radiolucent.

10. The method of claim 1 , wherein the oncoplastic device comprises a radiographically visible element.

11. The method of claim 1 , wherein the semi-rigid open framework is compliant.

12. The method of claim 1 , wherein placing the oncoplastic device into the cavity or space partially replaces a volume of the surgically removed tissue.

13. The method of claim 2 , wherein manipulating the tissue surrounding the oncoplastic device comprises pulling the surrounding tissue through the oncoplastic device.

14. The method of claim 2 wherein manipulating the tissue surrounding the oncoplastic device comprises suturing the surrounding tissue through the open framework.

15. A method of reconstituting the contour of a breast comprising:

placing an oncoplastic device into a cavity or void created by removal of a volume of breast tissue, the oncoplastic device comprising a body having a semi-rigid open framework to provide structural support to the cavity or void and formed of a bioabsorbable material, wherein the oncoplastic device is sized smaller than the cavity or void; and

manipulating remaining breast tissue surrounding the oncoplastic device,

wherein body fluids and tissue pass into the oncoplastic device to promote tissue regrowth within the device thereby reconstituting the contour of the breast.

16. The method of claim 15 , wherein manipulating remaining breast tissue comprises attaching tissues within the open framework.

17. The method of claim 15 , wherein the cavity or void has minimal overlying tissue.

18. The method of claim 17 , wherein the oncoplastic device has a flattened or low profile shape.

19. The method of claim 15 , wherein the oncoplastic device is sized so that it corresponds to the size of a tumor contained within the removed volume of breast tissue.

20. The method of claim 15 , wherein the semi-rigid open framework is compliant.

21. The method of claim 15 wherein the oncoplastic device comprises a radiographically visible element.

Assignments (6)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 047582/0020 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.
Reel/Frame 075455/0555 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
MERGER AND CHANGE OF NAME Recorded Jul 13, 2021
From: FOCAL THERAPEUTICS, INC.; HOLOGIC, INC.
To: HOLOGIC, INC.
Reel/Frame 056835/0532 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
SECURITY INTEREST Recorded Nov 26, 2018
From: FOCAL THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047582/0020 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2016
From: LEBOVIC, GAIL S.; WILLIS, DAVID B.; HERMANN, GEORGE D.; OLSON, JONATHAN M.
To: FOCAL THERAPEUTICS, INC.
Reel/Frame 038461/0865 →